Lale Kostakoglu

Lale Kostakoglu

UNVERIFIED PROFILE

Are you Lale Kostakoglu?   Register this Author

Register author
Lale Kostakoglu

Lale Kostakoglu

Publications by authors named "Lale Kostakoglu"

Are you Lale Kostakoglu?   Register this Author

100Publications

1571Reads

18Profile Views

End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma.

PET Clin 2019 Jul;14(3):307-315

Division of Hematology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55901, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2019.03.001DOI Listing
July 2019

PET-Derived Quantitative Metrics for Response and Prognosis in Lymphoma.

PET Clin 2019 Jul;14(3):317-329

Department of Medical Physics, 'Santa Croce e Carle' Hospital, Cuneo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2019.03.002DOI Listing
July 2019

The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.

J Urol 2019 02;201(2):322-331

Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2018.08.050DOI Listing
February 2019

Updating the role of FDG PET/CT for evaluation of lung cancer manifesting in nonsolid nodules.

Clin Imaging 2018 Nov - Dec;52:157-162. Epub 2018 Jul 6.

Department of Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2018.07.004DOI Listing
January 2019

Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study.

Abdom Radiol (NY) 2018 12;43(12):3462-3467

Division of Nuclear Medicine, Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-018-1665-2DOI Listing
December 2018

Quantitative comparison of pre-therapy Tc-macroaggregated albumin SPECT/CT and post-therapy PET/MR studies of patients who have received intra-arterial radioembolization therapy with Y microspheres.

Eur J Radiol 2018 Dec 21;109:57-61. Epub 2018 Oct 21.

Division of Nuclear Medicine, Icahn School of Medicine at Mount Sinai, New York, USA; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2018.10.015DOI Listing
December 2018

Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 (Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with Y microspheres.

EJNMMI Phys 2018 Aug 30;5(1):23. Epub 2018 Aug 30.

Division of Nuclear Medicine, Department of Radiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1141, New York, NY, 10029, USA.

View Article

Download full-text PDF

Source
https://ejnmmiphys.springeropen.com/articles/10.1186/s40658-
Publisher Site
http://dx.doi.org/10.1186/s40658-018-0222-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115317PMC
August 2018

Surveillance Imaging in HPV-related Oropharyngeal Cancer.

Anticancer Res 2018 03;38(3):1525-1529

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12380DOI Listing
March 2018

Guest Editorial.

Authors:
Lale Kostakoglu

Semin Nucl Med 2018 01 27;48(1):2-3. Epub 2017 Oct 27.

Nuclear Medicine and Molecular Imaging, Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2017.10.001DOI Listing
January 2018

Metabolic Tumor Volume Metrics in Lymphoma.

Semin Nucl Med 2018 01;48(1):50-66

Department of Medical Physics, 'Santa Croce e Carle' Hospital, Cuneo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2017.09.005DOI Listing
January 2018

Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using F-Fluciclovine PET/CT.

J Nucl Med 2017 10 6;58(10):1596-1602. Epub 2017 Apr 6.

Blue Earth Diagnostics (BED), Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.188375DOI Listing
October 2017

Reply: Fact Sheet About Interim and End-of-Treatment F-FDG PET/CT in Lymphoma.

Authors:
Lale Kostakoglu

J Nucl Med 2017 07 6;58(7):1179. Epub 2017 Apr 6.

Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place, Box 1141 New York, NY 10029 E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.190512DOI Listing
July 2017

The ideal dual-isotope imaging combination in evaluating patients with suspected infection of pelvic pressure ulcers.

Nucl Med Commun 2017 Feb;38(2):129-134

aDepartment of Radiology, Mount Sinai Medical Center, Nuclear Medicine Division bDepartment of Medicine, Mount Sinai Medical Center, Infectious Diseases Division cDepartment of Orthopedics, Mount Sinai Medical Center dIcahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000625DOI Listing
February 2017

Metabolic Tumor Volume: We Still Need a Platinum-Standard Metric.

J Nucl Med 2017 02 10;58(2):196-197. Epub 2016 Nov 10.

Mount Sinai Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.184663DOI Listing
February 2017

Response Assessment Criteria and Their Applications in Lymphoma: Part 2.

J Nucl Med 2017 Jan 22;58(1):13-22. Epub 2016 Nov 22.

Mount Sinai Hospital, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.184242DOI Listing
January 2017

FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.

Oncology (Williston Park) 2017 01;31(1):45-9

View Article

Download full-text PDF

Source
January 2017

General Biomarker Recommendations for Lymphoma.

J Natl Cancer Inst 2016 12 16;108(12). Epub 2016 Dec 16.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ (LR), Department of Pathology and Laboratory Medicine, University of North Carolina Medical School, Chapel Hill, NC (YF), Center for Cancer Research, National Cancer Institute, Bethesda, MD (LMS), Department of Medicine, Weill Cornell Medical College, New York, NY (AM), Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada (RG), Clinical Cancer Research Unit, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada (MC), Coordinating Center for Clinical Trials, National Cancer Institute, Bethesda, MD (LB), Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE (KF), Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH (ED), Department of Pathology, City of Hope Medical Center, Duarte, CA (JWCC), Biometrics Research Branch, National Cancer Institute, Bethesda, MD (LM), Department of Medicine, Weill Cornell Medicine, New York, NY (JPL), Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK), Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD (RFL), Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF), Department of Radiology, Mount Sinai Medical Center New York, NY (LK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080362PMC
December 2016

Optimization of yttrium-90 PET for simultaneous PET/MR imaging: A phantom study.

Med Phys 2016 Aug;43(8):4768

Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029; and Department of Cardiology, Zena and Michael A. Weiner Cardiovascular Institute and Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Icahn School of Medicine at Mount Sinai, New York, New York 10029.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.4958958DOI Listing
August 2016

Response Assessment Criteria and Their Applications in Lymphoma: Part 1.

J Nucl Med 2016 06 28;57(6):928-35. Epub 2016 Apr 28.

Stanford University Medical Center, Stanford, California

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.166280DOI Listing
June 2016

Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scan.

Leuk Lymphoma 2016 May 16;57(5):1083-93. Epub 2015 Nov 16.

b Department of Radiology, Division of Nuclear Medicine , Icahn School of Medicine at Mount Sinai , New York , NY , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1089437DOI Listing
May 2016

The evolving role of response-adapted PET imaging in Hodgkin lymphoma.

Ther Adv Hematol 2016 Apr;7(2):108-25

Division of Hematology-Oncology, Director, Tufts Cancer Center, Tufts Medical Center, 800 Washington Street, Box #245, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620715625615DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802505PMC
April 2016

Direct comparison of neck pinhole dual-tracer and dual-phase MIBI accuracies with and without SPECT/CT for parathyroid adenoma detection and localization.

Clin Nucl Med 2015 Jun;40(6):476-82

From the *Division of Nuclear Medicine, Department of Radiology, †Department of Otolaryngology, and ‡Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000778DOI Listing
June 2015

Radiographic extracapsular extension and treatment outcomes in locally advanced oropharyngeal carcinoma.

Head Neck 2014 Dec 13;36(12):1689-94. Epub 2014 Jan 13.

Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23512DOI Listing
December 2014

State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings.

Eur J Radiol 2014 Dec 28;83(12):2203-2223. Epub 2014 Sep 28.

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0720048X140045
Publisher Site
http://dx.doi.org/10.1016/j.ejrad.2014.09.012DOI Listing
December 2014

The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease.

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):135-43. Epub 2014 Nov 18.

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2014.1.135DOI Listing
December 2014

The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease.

Blood 2014 Nov;124(23):3356-64

Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-05-57
Publisher Site
http://dx.doi.org/10.1182/blood-2014-05-577627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467863PMC
November 2014

In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma.

J Clin Oncol 2014 Sep 28;32(25):2705-11. Epub 2014 Jul 28.

Martin Hutchings, Annika Loft, and Lena Specht, Rigshospitalet, Copenhagen, Denmark; Lale Kostakoglu and Richard Stern, Mount Sinai Medical Center; Morton Coleman, Weill Cornell Medical College/New York Presbyterian Hospital, New York; Dominick Lamonica and Myron S. Czuczman, Roswell Park Cancer Institute, Buffalo, NY; Jan Maciej Zaucha and Iwona Danielewicz, Medical University of Gdansk, Gdansk; Bogdan Malkowski, Centre of Oncology, Bydgoszcz, Poland; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo; Christina Nanni and Pier Luigi Zinzani, University Hospital S. Orsola-Malpighi, Bologna, Italy; Louis Diehl, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.2838DOI Listing
September 2014

Current role of FDG PET/CT in lymphoma.

Eur J Nucl Med Mol Imaging 2014 May 12;41(5):1004-27. Epub 2014 Feb 12.

Department of Radiology, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Box 1141, New York, NY, 10029, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-013-2686-2DOI Listing
May 2014

FDG-PET imaging for Hodgkin lymphoma: current use and future applications.

Clin Adv Hematol Oncol 2014 Jan;12(1):20-35

Tufts Medical Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
January 2014

Dual-isotope SPECT/CT impact on hospitalized patients with suspected diabetic foot infection: saving limbs, lives, and resources.

Nucl Med Commun 2013 Sep;34(9):877-84

Department of Radiology, Nuclear Medicine Division, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0b013e32836370a6DOI Listing
September 2013

State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".

Front Oncol 2013 Sep 4;3:212. Epub 2013 Sep 4.

Department of Radiology, Mount Sinai Medical Center , New York, NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762124PMC
September 2013

Radionuclide response assessment of breast cancer.

Authors:
Lale Kostakoglu

Semin Nucl Med 2013 Jul;43(4):299-316

Department of Radiology, Division of Nuclear Medicine, Mount Sinai Medical Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2013.03.001DOI Listing
July 2013

Interim 18F-FDG PET in Hodgkin lymphoma: would PET-adapted clinical trials lead to a paradigm shift?

J Nucl Med 2013 Jul;54(7):1082-93

Department of Radiology, Division of Nuclear Medicine, Mount Sinai Medical Center, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/content/54/7/1082.full.pdf
Web Search
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.113.120451
Publisher Site
http://dx.doi.org/10.2967/jnumed.113.120451DOI Listing
July 2013

Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?

Blood 2012 Dec 28;120(25):4913-20. Epub 2012 Aug 28.

Haematology Department and BMT Unit, Azienda Ospedaliera S. Croce e Carle, Via M.Coppino 26, Cuneo, Italy.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-03-40
Publisher Site
http://dx.doi.org/10.1182/blood-2012-03-403790DOI Listing
December 2012

Novel PET Radiotracers for Potential Use in Management of Lymphoma.

Authors:
Lale Kostakoglu

PET Clin 2012 Jan;7(1):83-117

Division of Nuclear Medicine, Department of Radiology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2011.12.002DOI Listing
January 2012

Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment setting.

Radiographics 2011 Mar-Apr;31(2):355-73

Department of Radiology, Mount Sinai Hospital, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://pubs.rsna.org/doi/10.1148/rg.312095765
Publisher Site
http://dx.doi.org/10.1148/rg.312095765DOI Listing
August 2011

Role of FDG PET/CT in staging of recurrent ovarian cancer.

Radiographics 2011 Mar-Apr;31(2):569-83

Division of Nuclear Medicine, Department of Radiology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.312105713DOI Listing
August 2011

Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma.

Eur J Haematol 2011 Apr 1;86(4):289-98. Epub 2011 Feb 1.

The Division of Nuclear Medicine and The Bone Marrow Transplant Program, The Mount Sinai Medical Center, New York,NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2010.01575.xDOI Listing
April 2011

The optimized evaluation of diabetic foot infection by dual isotope SPECT/CT imaging protocol.

J Foot Ankle Surg 2010 Nov-Dec;49(6):529-36. Epub 2010 Sep 18.

Nuclear Medicine Service, Nuclear Medicine Division, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.jfas.2010.07.010DOI Listing
March 2011

Extraperitoneal urine leak after renal transplantation: the role of radionuclide imaging and the value of accompanying SPECT/CT - a case report.

BMC Med Imaging 2010 Oct 20;10:23. Epub 2010 Oct 20.

The Division of Nuclear Medicine, Department of Radiology, The Mount Sinai School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2342-10-23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984463PMC
October 2010

PET/CT evaluation of cervical cancer: spectrum of disease.

Radiographics 2010 Sep;30(5):1251-68

Department of Radiology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.305105703DOI Listing
September 2010

FDG PET with contrast-enhanced CT: a critical imaging tool for laryngeal carcinoma.

Radiographics 2010 Sep;30(5):1353-72

Department of Radiology, Mount Sinai Medical Center, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.305095764DOI Listing
September 2010

Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck.

Int J Radiat Oncol Biol Phys 2008 Jul 6;71(3):682-8. Epub 2008 Feb 6.

Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.10.055DOI Listing
July 2008

Variables Involved in Measuring Cancer Response to Treatment.

Authors:
Lale Kostakoglu

PET Clin 2008 Jan 27;3(1):13-36. Epub 2008 Nov 27.

PET/CT Oncology and Research, Division of Nuclear Medicine, Department of Radiology, Mount Sinai Medical Center, One Gustave Levy Place, Box 1141, New York, NY 10029, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2008.08.002DOI Listing
January 2008

FDG-PET Evaluation of Response to Treatment.

Authors:
Lale Kostakoglu

PET Clin 2008 Jan 27;3(1):37-75. Epub 2008 Nov 27.

Division of Nuclear Medicine, Department of Radiology, Mount Sinai Medical Center, One Gustave Levy Place, Box: 1141, New York, NY 10029, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cpet.2008.09.001DOI Listing
January 2008

FDG PET/CT imaging to rule out extrahepatic metastases before liver transplantation.

Clin Nucl Med 2007 Dec;32(12):947-8

Division of Nuclear Medicine, Department of Radiology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0b013e3181598cefDOI Listing
December 2007

Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors.

J Clin Oncol 2007 Feb;25(5):540-7

Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.07.8097DOI Listing
February 2007

Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement.

Leuk Lymphoma 2007 Feb;48(2):342-8

Center for Lymphoma and Myeloma, Division of Hematology/Oncology, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190601059720DOI Listing
February 2007

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.

Cancer 2006 Dec;107(11):2678-87

Department of Radiology, Division of Nuclear Medicine, Mount Sinai School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22276
Publisher Site
http://dx.doi.org/10.1002/cncr.22276DOI Listing
December 2006

Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?

Cancer 2006 Oct;107(7):1425-8

Center for Lymphoma and Myeloma, Division of Hematology/Oncology, Weill Medical College of Cornell University, New York Presbyterian Hospital, New York, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22178
Publisher Site
http://dx.doi.org/10.1002/cncr.22178DOI Listing
October 2006

Lymphoma imaging: nuclear medicine.

Cancer Treat Res 2006 ;131:363-412

Department of Radiology, Division of Nuclear Medicine, The New York Presbyterian Hospital Weill Medical College of Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-29346-2_13DOI Listing
June 2006

Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.

Clin Genitourin Cancer 2006 Mar;4(4):249-56

Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155876731170147
Publisher Site
http://dx.doi.org/10.3816/CGC.2006.n.003DOI Listing
March 2006

Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma.

Cancer 2006 Feb;106(3):616-22

Center for Lymphoma and Myeloma, Division of Hematology/Oncology, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.21606
Publisher Site
http://dx.doi.org/10.1002/cncr.21606DOI Listing
February 2006

Radioimmunotherapy of prostate cancer using 90Y- and 177Lu-labeled J591 monoclonal antibodies: effect of multiple treatments on myelotoxicity.

Clin Cancer Res 2005 Oct;11(19 Pt 2):7195s-7200s

Department of Radiology, Division of Nuclear Medicine, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-1004-0023DOI Listing
October 2005

Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.

J Clin Oncol 2005 Aug;23(24):5696-704

Center for Lymphoma and Myeloma, Division of Hematology and Medical Oncology, Starr Bldg Rm 340, Weill Medical College of Cornell University and New York Presbyterian Hospital, 520 E 70th St, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.14.803
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.14.803DOI Listing
August 2005

PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake.

Radiographics 2004 Sep-Oct;24(5):1411-31

Division of Nuclear Medicine, Department of Radiology, New York Presbyterian Hospital, Weill Medical College of Cornell University, 525 E 68th St, Starr No 221, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.245035725DOI Listing
July 2005

Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer.

J Clin Oncol 2005 Jul 18;23(21):4591-601. Epub 2005 Apr 18.

Department of Urology, Weill Medical College of Cornell University, 525 E 68th St, E-300, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.160DOI Listing
July 2005

Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen.

J Nucl Med 2005 May;46(5):850-8

Division of Nuclear Medicine, Department of Radiology, New York Presbyterian Hospital-Weill Medical College of Cornell University, 525 E. 68th Street, STARR-221, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
May 2005

Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu?

J Nucl Med 2005 Apr;46(4):634-41

Division of Nuclear Medicine, Department of Radiology, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
April 2005

Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer.

J Clin Oncol 2004 Jul 1;22(13):2522-31. Epub 2004 Jun 1.

Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.09.154DOI Listing
July 2004

Radionuclide imaging of thoracic malignancies.

Thorac Surg Clin 2004 Feb;14(1):95-112

Weill Medical College, Cornell University, 1300 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1547-4127(04)00034-9DOI Listing
February 2004

The role of FDG-PET imaging in the management of lymphoma.

Clin Adv Hematol Oncol 2004 Feb;2(2):115-21

Division of Nuclear Medicine, Department of Radiology, Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
February 2004

PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.

J Nucl Med 2004 Jan;45(1):56-68

Division of Nuclear Medicine, Department of Radiology, New York Presbyterian Hospital, Weill Medical College, Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
January 2004

Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen.

J Urol 2003 Nov;170(5):1717-21

Department of Urology, Division of Nuclear Medicine, New York-Presbyterian Hospital/Weill Medical College of Cornell University, 525 East 68th Street, Starr 900, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000091655.77601.0cDOI Listing
November 2003

Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen.

Semin Oncol 2003 Oct;30(5):667-76

Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
October 2003

Clinical role of FDG PET in evaluation of cancer patients.

Radiographics 2003 Mar-Apr;23(2):315-40; quiz 533

Division of Nuclear Medicine, Department of Radiology, New York Presbyterian Hospital, Weill Cornell Medical Center, 525 E 68th St, Starr No. 221, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.232025705DOI Listing
June 2003

18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma.

J Nucl Med 2003 Feb;44(2):224-39

Division of Nuclear Medicine, Department of Radiology, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
February 2003

PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

J Nucl Med 2002 Aug;43(8):1018-27

Division of Nuclear Medicine, Department of Radiology, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
August 2002

The utility of monoclonal antibodies in the imaging of prostate cancer.

Semin Urol Oncol 2002 Aug;20(3):211-8

James Buchanan Brady Department of Urology, The New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
August 2002

Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?

Authors:
Lale Kostakoglu

Clin Lymphoma 2002 Mar;2(4):242-8

Department of Radiology, Division of Nuclear Medicine, The New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
March 2002